一种针对猫过敏患者的疫苗正在研制中

Cat allergy got you in mew-sery? This news may change your life fur-ever.

猫过敏，你得了吗?这个消息可能永久改变你的生活。

A team of scientists from the Swiss firm HypoPet AG has developed a vaccine to combat the feline-produced protein Fel d 1, to which 10% of humans are allergic, according to their press release.

瑞士HypoPet AG公司的一组科学家，已经开发出一种疫苗来对抗猫产生的蛋白质fel d 1，据他们的新闻稿显示，10%的人对它过敏。

After analyzing data from four separate studies involving a total of 54 kitties, the antidote, called HypoCat, has already demonstrated its success.

在分析了四项涉及54只小猫的独立研究的数据后，这种名为“低猫”的解药已经证明了它的成功。

“Our HypoCat vaccine is able to produce high levels of antibodies in cats,” writes Gary Jennings, CEO of HypoPet AG, in the statement. “These antibodies can bind and neutralize the Fel d 1 allergen produced by the animals.”

HypoPet AG公司的首席执行官加里·詹宁斯在声明中写道：“我们的低剂量猫流感疫苗，能够在猫体内产生高水平的抗体。”“这些抗体可以结合并中和动物产生的Fel d1过敏源。”

Researchers say they are “pressing ahead with registration studies and discussions with European and US regulators” to bring the drug to market, which would certainly change lives.

研究人员说，他们正在“推进注册研究，与欧洲和美国监管机构的讨论”，尽快将这种药物推向市场，这肯定会改变人们的生活。

The vaccine would help those with cat allergies avoid typical reactions such as rashes, nasal congestion and irritated eyes, while also lowering their risk of exacerbating asthma or developing chronic respiratory issues.

这种疫苗可以帮助那些患有猫过敏的人避免典型的反应，如皮疹、鼻塞和眼睛发炎，同时也降低他们患哮喘或慢性呼吸道疾病的风险。